Form 4 for AVTR Avantor, Inc.
Accepted 2026-05-05 19:40:26 ET · period of report 2026-05-01 · accession 0001628280-26-030825 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-05 19:40 | 2026-05-01 | AVTR | Brellier Ludovic | EVP, Bioscience, Medtech | A - Grant | $0.00 | +146.6K | 146.6K | New | $0 |
| D | 2026-05-05 19:40 | 2026-05-01 | AVTR | Brellier Ludovic | EVP, Bioscience, Medtech | A - Grant | $0.00 | +246.0K | 246.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-01 | A | A | 146,566 | $0.00 | 146,566 | D | — | — | (F1) Reflects a grant of restricted stock units that vest in three equal annual installments beginning on May 1, 2027. |
| 2 | Derivative | Stock Options (Right to Buy) | 2026-05-01 | A | A | 246,002 | $0.00 | 246,002 | D | $8.76 · — to 2036-05-01 | 246,002 Common Stock | (F2) Reflects a grant of stock options that vest in three equal annual installments beginning on May 1, 2027. |